The drug "Rumalon" belongs to the group of chondroprotective medicines. Also, this medication can be attributed to stimulants of regeneration.
The drug "Rumalon", instructions for usewhich gives a detailed description of it, is made in the form of a solution intended for injection. The drug is a liquid having a yellowish-brown color. The solution has a smell of metacresol. In the pharmacy network the drug is sold in ampoules made of light-protective glass. Their volume can be one or two milliliters. Ampoules with the drug are packaged in contoured cell packs. The pack is additionally equipped with a first opening control, which is two protective stickers.
The drug "Rumalon" (instructions for useindicates its composition) contains the glucosaminoglycan-peptide complex as the main active substance. This component is purified by special technological processes and concentrated extract, obtained from cartilage tissue and brain (bone) young animals or calves.
The drug "Rumalon", instructions for usewhich describes the main pharmacological properties of the drug, has an effect on the body, through which the chondroprotective (protective) effect is achieved.
The drug helps to reduce activitythe main mass of enzymes that destroy the joint surface, which is a cartilaginous tissue. The drug deactivates the processes of destruction, normalizes the biological synthesis of sulfated mucopolysaccharides, and also enhances the metabolic processes in the hyaline tissues. Being a biogenic stimulator of animal origin, the drug restores the structure of the articular cartilage tissue.
This process is due to the abilitythe main active substance to increase in the body the production of glucosaminoglycans and collagen, acting as the main building material. The drug deactivates and reduces the action of cartilage-destroying enzymes, improves the supply of nutrients to the joint, and also stimulates the amount of liquid necessary for its normal functioning. By its action on the body, the drug reduces the risk of progression of osteoarthritis. The cause of this disease is the thinning of the plate and the change in the surface of the cartilage of the joint.
The drug "Rumalon", instructions for usewhich describes the most common pathologies in which he is shown, is prescribed in the presence of diseases of the musculoskeletal system, which are associated with destructive (degenerative) processes in cartilage tissue. Such ailments include the following:
- Spondylosis;
- arthrosis;
- chondromalation of patella (necrosis of cartilaginous tissue);
- coxarthrosis;
- meniscopathy (pathology of the joint knee joint, which is a cartilaginous tissue);
- gonarthrosis;
- spondylarthrosis.
The drug "Rumalon", a description of the method of applicationwhich can be found in the instructions, is injected into the body by intramuscular injection. The course of treatment is six to eight weeks and is conducted twice a year. Reduction of pain symptoms and increased mobility of the joints is observed fourteen days after the start of treatment. The drug "Rumalon", reviews of which testify to the aggravation of the course of pathological processes after the first injections, is not canceled by a specialist before the end of the course of therapy, since these phenomena are temporary and pass by themselves.
